Tel:
Fax:
Email:
Creative Biolabs
Product

NeuroMab™ Anti-GARP BBB Shuttle Antibody, Clone LHG-10.3

[CAT#: NRZP-1022-ZP3031]

Host Species:
Humanized
Species Reactivity:
Human; Cynomolgus Monkey
Applications:
FC; Inhib; Block; In Vitro; In Vivo

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human; Cynomolgus Monkey

Clonality

Monoclonal

Host Species

Humanized

Clone Number

LHG-10.3

Applications

FC; Inhib; Block; In Vitro; In Vivo
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

GARP

Official Name

LRRC32

Full Name

Leucine Rich Repeat Containing 32

Alternative Names

Leucine Rich Repeat Containing 32 ; Glycoprotein A Repetitions Predominant ; Transforming Growth Factor Beta Activator LRRC3; Leucine-Rich Repeat-Containing Protein 3; D11S833E ; Garpin ; GARP ; LRRC32
Product Pictures
FCM

Figure 1 Cross-reactivity with macaque GARP-TGFβ measured on cells by FACS. 293E cells were transfected with human/cynomolgus GARP and human/cynomolgus TGFB. LHG-10-D and affinity-optimized variants cross-react with cynomolgus GARP-TGFB.

Inhib

Figure 2 MHGARP8 and LHG-10 inhibit the suppressive activity of human Tregs in vitro.

Inhib

Figure 3 MHGARP8 and LHG-10 inhibit human Treg from producing active TGF-β.

After a short in vitro amplification, human CD4+CD25hiCD127lo cells (Tregs) were re-stimulated with anti-CD3/CD28 coated beads during 24 hours, in the presence or absence of the indicated mAbs (10 μg/ml). Cells lysates were analyzed by Western Blot with antibodies against phosphorylated SMAD2 (pSMAD2), as a read-out for active TGF-β production, or β-ACTIN (loading control).

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Send inquiry